Independent Medical Education (IME)

Organization
Genentech
Type
Foundation
Comments
Grant requests must be submitted at least 60 days prior to the project/program/event start date.
Brief Description

Genentech supports grants for independent medical education in an effort to advance excellence in medicine and healthcare and improve patient health outcomes by enhancing the knowledge of the medical community.

Independent Medical Education (IME) is generally defined as education for healthcare professionals (HCPs) provided by an independent educational provider, such as a community hospital, academic center, society/association or medical education and communication company.

Before you submit an application, we encourage you to explore the following materials to learn more about our opportunities for funding, eligibility requirements and considerations, and the process for submitting a proposal within our system.

All aspects related to IME including but not limited to the agenda, content, and faculty, must remain fully independent and be under the sole control of the activity organizers. Genentech will not provide any guidance to the IME provider. All accredited programs must follow the standards set forth in the ACCME Standards for Integrity and Independence in Accredited Continuing Education.

Genentech/Roche will consider funding requests in the following disease states:

  • Age-Related Macular Degeneration
  • Alzheimer's Disease
  • Asthma
  • Basal Cell Carcinoma
  • Bladder Cancer
  • Chronic Urticaria
  • COVID
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • Food Allergy
  • Geographic Atrophy
  • Giant Cell Arteritis
  • Hematologic Malignancy (Multiple Malignancies)
    • Lymphoma
    • Diffuse Large B-Cell
    • Follicular
    • Non-Hodgkins
  • Leukemia
    • Acute Myeloid
    • Chronic Lymphocytic
  • Hemophilia
  • Hepatocellular Carcinoma
  • Idiopathic Pulmonary Fibrosis
  • Influenza
  • Idiopathic Pulmonary Fibrosis
  • Influenza
  • Lung Cancer (Multiple Subtypes)
    • Non-Small-Cell
    • Non-Small Cell ALK Positive
    • Non-Small Cell RET Altered
    • Non-Small Cell ROS1 Positive
    • Small-Cell
  • Melanoma
  • Multiple Sclerosis
  • Nasal Polyps
  • Neuromyelitis Optica
  • NTRK Fusion Cancers
  • Pan-Tumor
  • Pemphigus Vulgaris
  • Retinal Vein Occlusion
  • Renal Cell Carcinoma
  • Rheumatoid Arthritis
  • Scleroderma
  • Spinal Muscular Atrophy
  • Stroke
  • Thyroid Cancer RET Altered
  • Vasculitis